Related Experiment Video
Updated: Jan 10, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Genomic features of Streptococcus pneumoniae associated with recurrent invasive pneumococcal disease
Sarah A M Smith1, Rebecca J Rockett2, Shahin Oftadeh3
1Centre for Infectious Diseases and Microbiology - Public Health, Westmead Hospital, Westmead, NSW, Australia; NSW Invasive Pneumococcal Disease Reference Laboratory, Institute of Clinical Pathology and Medical Research, NSW Health Pathology, Westmead, NSW, Australia; School of Medical Sciences and Sydney Infectious Diseases Institute, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Abstract:
Invasive pneumococcal disease (IPD) is a major cause of morbidity and mortality worldwide, particularly in children and the elderly. Recurrent IPD (rIPD) is more challenging to manage and differentiate between re-infection with a new strain of Streptococcus pneumoniae, and relapse associated with host immunodeficiency or unrecognised antimicrobial resistance (AMR). This study examined genomic features of S. pneumoniae associated with rIPD. A set of 140 S. pneumoniae isolates from 67 patients with rIPD was investigated. All isolates were subjected to Quellung serotyping and whole-genome sequencing to determine episodes of rIPD relapse and reinfection and to identify AMR genes. In the first and second episodes, 33 (49%) of cases of rIPD were associated with different serotypes of S. pneumoniae and were classified as reinfections. In 34 cases, both presentations were caused by S. pneumoniae of the same serotype. Genomic comparison of pneumococci associated with these rIPD episodes indicated that a further 7% (5/67) were reinfections and the rest (29 cases of rIPD; 43%) were cases of relapse caused by genomically closely related strains. rIPD cases with over 6000 mutations between core genome in S. pneumoniae were classified as reinfection, while endogenous relapse cases were characterised by fewer than 34 mutations between the core genomes of S. pneumoniae. rIPD recurrence within a year was more likely to be a relapse than a reinfection. Relapse cases were more likely to have AMR markers present in the initial episode, with no significant evidence of AMR acquisition between episodes. These findings suggest a role for S. pneumoniae genome sequence analysis in differentiating endogenous relapse from exogenous reinfection in rIPD to inform clinical management and public health follow-up.
Insights
Genomic analysis of Streptococcus pneumoniae helps distinguish recurrent invasive pneumococcal disease (IPD) relapse from reinfection. Relapse cases often show antimicrobial resistance (AMR) markers early, guiding clinical management.
Area of Science:
- Microbiology
- Genomics
- Infectious Diseases
Background:
- Invasive pneumococcal disease (IPD) poses a significant global health burden.
- Recurrent IPD (rIPD) presents diagnostic challenges, requiring differentiation between relapse and reinfection.
- Understanding the genomic basis of rIPD is crucial for effective management.
Purpose of the Study:
- To investigate the genomic features of Streptococcus pneumoniae isolates from patients with recurrent IPD (rIPD).
- To differentiate between relapse and reinfection in rIPD using whole-genome sequencing.
- To identify potential associations between genomic characteristics, antimicrobial resistance, and rIPD recurrence patterns.
Main Methods:
- Whole-genome sequencing and Quellung serotyping of 140 S. pneumoniae isolates from 67 rIPD patients.
- Genomic comparison to identify mutations and classify episodes as relapse or reinfection.
- Analysis of antimicrobial resistance (AMR) genes in relation to rIPD type.
Main Results:
- 49% of rIPD cases involved different serotypes (reinfection), while 43% were caused by closely related strains (relapse).
- Reinfection was indicated by >6000 core genome mutations; relapse by <34 mutations.
- Relapse cases were more likely to have initial AMR markers, with no significant AMR acquisition observed.
Conclusions:
- Genome sequencing effectively distinguishes S. pneumoniae relapse from reinfection in rIPD.
- Identifying relapse versus reinfection can inform clinical decisions and public health strategies for rIPD.
- Genomic surveillance of S. pneumoniae is vital for managing recurrent infections and understanding AMR dynamics.
More Related Videos
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon...
Fimbriae, Pili, and Axial Filaments
Endocarditis II: Clinical Features of Infective Endocarditis

